MUHAMMAD CHOUDHRY: Open Payments
NPI 1396003588 · ATWATER, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,003 in 38 payments from 16 companies in 2025. Trend: 2023 $367 · 2024 $913 · 2025 $1,003
Food & beverage: $1,003
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 12 | $229 |
| Madrigal Pharmaceuticals | 2 | $149 |
| Ardelyx, Inc. | 1 | $122 |
| Sumitomo Pharma America, Inc. | 3 | $105 |
| Lilly USA, LLC | 6 | $103 |
| Novo Nordisk Inc | 2 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $45 |
| Boston Scientific Corporation | 1 | $34 |
| ABIOMED | 1 | $30 |
| Phathom Pharmaceuticals, Inc. | 2 | $28 |
Products named: FANAPT, REZDIFFRA, IBSRELA, GEMTESA, MOUNJARO, HETLIOZ, CAPLYTA, WaveWriter Alpha Prime 16.
Industry payments across CA — which companies pay providers there.
